(Q33872413)

English

Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid (English)

1 reference

Europe PubMed Central

29 July 2017

author name string

Baures PW

1

1 reference

Europe PubMed Central

29 July 2017

Oza VB

2

1 reference

Europe PubMed Central

29 July 2017

Peterson SA

3

1 reference

Europe PubMed Central

29 July 2017

Kelly JW

4

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

29 July 2017

Bioorganic & Medicinal Chemistry

1 reference

Europe PubMed Central

29 July 2017

7

1 reference

Europe PubMed Central

29 July 2017

1339-1347

1 reference

Europe PubMed Central

29 July 2017

7

1 reference

Europe PubMed Central

29 July 2017

Alternative conformations of amyloidogenic proteins govern their behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial amyloidotic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibiting transthyretin amyloid fibril formation via protein stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovering transthyretin amyloid fibril inhibitors by limited screening

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibiting transthyretin conformational changes that lead to amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyanohydridoborate anion as a selective reducing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900066-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0968-0896(99)00066-8

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33872413&oldid=1958877196"